Roche will publish its Half Year Results for 2018 prior to the opening of the Swiss Stock Exchange on Thursday, 26th July 2018. 7:00 CEST / 6:00 BST / 1:00 AM EDT / 10:00 PM PDT (evening before) Release will be e-mailed and posted on the Roche IR website click here. Presentation slides will be posted on the Roche IR website click here. We would like to invite you to watch the live video webcast or to dial in as outlined below:
Thursday, 26th July, 2018 13:00 - 14:30 CEST / 12:00 - 13:30 BST 07:00 - 08:30 AM EDT / 04:00 - 05:30 AM PDT Live video webcast and conference call will start with presentations by senior management followed by a Q&A session (questions can be asked via phone and webcast).
Presenters: Severin Schwan, CEO Roche Group Alan Hippe, Chief Financial and IT Officer Daniel O'Day, CEO Roche Pharmaceuticals Roland Diggelmann, CEO Roche Diagnostics
The live video webcast can be accessed via ir.roche.com. To listen to the conference call, please dial in to the conference 10-15 min prior to the scheduled start, using the following numbers: +41 (0) 58 310 5000 (Europe and ROW) +44 (0) 207 107 0613 (UK) +1 (1) 631 570 5613 (USA Toll Free) A replay of the webcast will be available on demand on the Roche website. > click here Best regards, Karl Mahler Head of Investor Relations

Roche Investor Relations
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Susann Manchado Phone: +41 61-68-75619 e-mail: susann.manchado@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.